Citadel Advisors
PDLI

Citadel Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Citadel Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17,200
Closed -$50K – 10388
2018
Q4 		$50K Sell
17,200
-3,000
-15% -$8.24K ﹤0.01% 8494
2018
Q3 		$53K Buy
20,200
+3,800
+23% +$9.33K ﹤0.01% 8799
2018
Q2 		$38K Sell
16,400
-600
-4% -$1.68K ﹤0.01% 8500
2018
Q1 		$50K Buy
+17,000
New +$46.4K ﹤0.01% 7929
2017
Q2 		– Sell
-29,100
Closed -$66K – 8606
2017
Q1 		$66K Buy
29,100
+14,300
+97% +$31.6K ﹤0.01% 6981
2016
Q4 		$31K Buy
+14,800
New +$41.3K ﹤0.01% 6987
2016
Q2 		– Sell
-16,900
Closed -$56K – 7974
2016
Q1 		$56K Sell
16,900
-12,500
-43% -$39K ﹤0.01% 6224
2015
Q4 		$104K Buy
29,400
+9,400
+47% +$39.3K ﹤0.01% 6637
2015
Q3 		$101K Sell
20,000
-6,000
-23% -$34.4K ﹤0.01% 6952
2015
Q2 		$167K Sell
26,000
-14,100
-35% -$94.4K ﹤0.01% 6545
2015
Q1 		$282K Buy
40,100
+37,100
+1,237% +$269K ﹤0.01% 5743
2014
Q4 		$23K Sell
3,000
-30,400
-91% -$241K ﹤0.01% 7725
2014
Q3 		$249K Buy
33,400
+25,600
+328% +$238K ﹤0.01% 5488
2014
Q2 		$76K Sell
7,800
-600
-7% -$5.35K ﹤0.01% 6448
2014
Q1 		$70K Sell
8,400
-1,800
-18% -$15.4K ﹤0.01% 6501
2013
Q4 		$86K Buy
10,200
+8,000
+364% +$67.4K ﹤0.01% 5727
2013
Q3 		$18K Sell
2,200
-10,300
-82% -$82.8K ﹤0.01% 6297
2013
Q2 		$97K Buy
+12,500
New +$97.5K ﹤0.01% 5253

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Citadel Advisors's PDLI Position: Q4 2020 in Review

Citadel Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 1,957,423 shares — an estimated $6.17M sold.

Citadel Advisors first reported a position in PDLI in Q2 2013 and held it in 29 quarters. The position peaked at $12.4M in Q1 2017. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Citadel Advisors reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Citadel Advisors sold 1,957,423 PDL BioPharma, Inc. shares in Q4 2020, an estimated $6.17M.
  • Citadel Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 29 quarters.
  • Citadel Advisors's PDL BioPharma, Inc. position peaked at $12.4M in Q1 2017.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.